參考文獻 |
Child, S. L.; Patrick Stahly, G.; Park, A. The Salt-Cocrystal Continuum: The Influence of Crystal Structure on Ionization State. Mol. Pharmaceutics 2007, 4 (3), 323-338.
Schultheiss, N.; Newman, A. Pharmaceutical Cocrystals and Their Physicochemical Properties. Cryst. Growth Des. 2009, 9 (6), 2950-2967.
Basavoju, S.; Boström, D.; Velaga, P. Pharmaceutical Cocrystal and Salts of Norfloxacin. Cryst. Growth Des. 2006, 6 (12), 2699-2708.
Friščić, T.; Jones, W.; Cocrystal Architecture and Properties: Design and Building of Chiral and Racemic Structures by Solid-solid Reactions. Faraday Discuss. 2007, 136, 167-168.
Christine, I. S.; N. Jung.; Moritz, B.; Ute, S.; Stefan B. The Hydrogen Bond and Crystal Engineering. Chem. Soc. Rev. 1993, 22 (6), 397-407.
Lü, Jian; Han, L. W.; Lin, J. X.; Liu, T. F.; Cao, R. Rare Case of a Triple-Starnded Molecular Braid in an Organic Cocrystal. Cryst. Growth Des. 2010, 10 (10), 4217-4220.
Lehn, J. M.; Supramolecular Chemistry: from Molecular Information Towards Self-organization and Complex Matter. Rep. Prog. Phys. 2004, 67 (3), 249-265.
Almarsson, O.; Zaworotko, M. J. Crystal Engineering of the Composition of Pharmaceutical phases. Do Pharmaceutical Co-crystals represent a New Path to Improved Medicines? Chem. Commun. 2004, (17), 1889-1896.
Thomas, R.; Kulkarni, G. U. Hydrogen Bonding in Proton-Transfer Complexes of Cytosine with Trimesic and Pyromellitic Acids. J. Mol. Struct. 2008, 873(1-3), 160-167.
Lemmerer, A.; Bernstein, J.; Kahlenberg, V. Hydrogen Bonding Patterns of the Co-crystal Containing the Pharmaceutical Active Ingredient Isoniazid and Terephthalic Acid. J. Chem. Crystallor. 2011, 41 (7), 991-997.
Hickey, M. B.; Peterson, M. L.; Scoppettuolo, L. A.; Morrisette, S. L.; Vetter, A. Guzman, H.; Remenar, J. F.; Zhang, Z.; Tawa, M. D.; Haley, S.; Zaworotko, M. J.; Almarsson, Ö. Performance Comparison of a Co-crystal of Carbamazepine with Marketed Product. Eur. J. Pharm. Biopharm. 2007, 67 (1), 112–119.
Sokolov, A. N.; Friscic, T.; MacGillivray, L. R. Enforced Face-to-Face Stacking of Organic Semiconductor Building Blocks within Hydrogen-Bonded Molecular Cocrystals. J. Am. Chem. Soc. 2006, 128 (9), 2806–2807.
Koshima, H.; Miyauchi, M. Polymorphs of a Cocrystal with Achiral and Chiral Structures Prepared by Pseudoseeding: Tryptamine/ Hydrocinnamic Acid. Cryst. Growth Des., 2001, 1 (5), 355–357.
Cho, W.; Lee, H. J.; Oh, M. Growth-Controlled Formation of Porous Coordination Polymer Particles J. Am. Chem. Soc. 2008, 130 (50), 16943–16946.
Trask, A. V.; Jones, W. Crystal Engineering of Organic Cocrystals by the Solid-State Grinding Approach. Top Curr. Chem. 2005, 254, 41-70.
Shu, C. C.; Lin, S. T. Prediction of Drug Solubility in Mixed Solvent Systems Using the COSMO-SAC Activity Coefficient Model. Ind. Eng. Chem. Res. 2011, 50 (1), 142-147.
Portalone, G.; Colapietro, M. Solid-Phase Molecular Recognition of Cytosine Based on Proton-Transfer Reation. J. Chem. Crystallogr. 2009, 39 (3), 193-200.
Martins, F. T.; Doriguetto, A. C.; Ellena, J. From Rational Design of Drug Crystals to Understanding of Nucleic Acid Structures: Lamivudine Duplex. Cryst. Growth Des. 2010, 10 (2), 676-684.
Balasubramanian, T.; Muthiah, P. T.; Robinson, W. T. Cytosine-Carboxylate Interactions: Crystal Structure of Cytosinium Hydrogen Maleate. Bull. Chem. Soc. Jpn. 1996, 69 (10), 2919-2922.
Sellergren, B. Imprinted Polymers with Memory for Small Molecules, Proteins, or Crystals. Angew. Chem. Int. Ed. 2000, 39 (6), 1031-1037.
Pabo, C. O. Protein-DNA Recognition. Annu. Rev. Biochem. 1984, 53, 293-321.
Sarai, A.; Kono, H. Protein-DNA Recognition Patterns and Predictions. Annu. Rev. Biophys. Biomol. Struct. 2005, 34, 379-398.
Balzani, V.; Credi, A.; Venturi, M. Controlled Disassembling of Self-Assembling Systems: Toward Artfical Molecular-Level Devices and Machines. Proc. Natl. Acad. Sci. 2002, 99 (8), 4814-4817.
Barker, D. L.; Marsh, R. E. The Crystal Structure of Cytosine. Acta. Cryst. 1964, 17 (12), 1581-1587).
Jeffrey, G. A.; Kinoshita, Y. The Crystal Structure of Cytosine Monohydrate. Acta. Cryst. 1963, 16 (1), 20-28.
Newman, A. W.; Byrn, S. R. Solid-state analysis of the active pharmaceutical ingredient in drug products Drug Discovery Today 2003, 8 (19), 898-904.
Tiwary, A. K. Modification of Crystal Habit and Its Role in Dosage Form Performance Drug Dev. Ind. Pharm. 2001, 27 (7), 699-709.
Haines, P. J.; Wiburn, F. W. Differential Thermal Analysis and Differential Scanning Calorimetry. InThermal Methods of Analysis, 1st ed.; Blackie Academic and Professional: Scotland, 1995; pp. 69-114.
Pavia, D. L.; Lampman, G. M.; Kriz, G. S. Infrared Spectroscopy. InIntroduction to Spectroscopy, 3rd ed.; Brooks/COLE Thomson Learning: Mississippi, 2001, pp. 13-24.
Gotoh, K.; Masuda, H.; Higashitani, K. Powder-Handling Operation. Chapter 5 of InPowder Technology Handbook, 2nd ed.; Marcel Dekker: New York, 1997; pp. 720-730.
Gotoh, K.; Masuda, H.; Higashitani, K. Fundamental Properties of Powder Beds. InPowder Technology Handbook, 2nd ed.; Marcel Dekker: New York, 1997; pp. 413-423.
Gotoh, K.; Masuda, H.; Higashitani, K. Fundamental Properties of Powder Beds. InPowder Technology Handbook, 2nd ed.; Marcel Dekker: New York, 1997; pp. 659-661.
Murthy, N. S.; Reidinger, F. X-ray Analysis. InMaterials Chracterization and Chemical Analysis, 2nd ed.; Sibilia, J. P.. Ed.; Wiley-Vch: New York, 1996, pp. 143-149.
Huang, T. C. Automatic X-ray Single Crystal Structure Analysis System for Small Molecule The Rigaku J. 2004, 21 (2), 43-46.
Zhang, Y.; Grant, D. J. W. Similarity in Structures of Racemic and Enantiomeric Ibuprofen Sodium Dehydrates Acta Crystallogr. C, 2005, 61 (9), pp. m435-m438.
Hansen, L. Kr. ; Perlovich, G. L.; Baueer-Brandl, A. Redetermination and H-atom Refinement of (S)-(+)-Ibuprofen Acta Crystallogr. E: Struct. Rep. Online 2003, 59 (9), 1357-1358.
Hansen, L. Kr.; Perlovich, G. L.; Bauer-Brandl, A. Redetermination and H-atom Refinement of (S)-(+)-Ibuprofen. corrigendum Acta Crystallogr. E 2006, 62 (7), e17-e18.
Ciacovazzo, C.; Monaco, H. L.; Artioli, G.; Viterbo, D.; Ferraris, G.; Gilli, G.; Zanotti, G.; Catti, M. Experimental Method in X-ray Andneutron Crystallography. InFundamentals of Crystallography, 2nd ed.; Oxford University Press: New York, 2002; p. 336.
Glusker, J. P.; Trueblood, K. N. Experimental Measurement. InCrystal Structure Analysis A Primer, 2nd ed.; Oxford University Press: New York, 1985; pp. 42-47.
Skoog, D. A.; Holler, F. J.; Nieman, T. A. Components of Optical Instrument. InPrinciples of Instrumental Analysis, 5th ed.; Thomson Learning: Mississippi, 2001; pp. 182-183.
Bauer-Brandl, A. Polymorphic Transitions of Cimetidine During Manufacture of Solid Dosage Forms Int. J. Pharm. 1996, 140 (2), 195-206.
Brittain, H. G.; Elder, B. J.; Isbeter, P. K.; Salemo, A. H. Solid-State Fluorescence Studies of Some Polymorphs of Diflunisal Pharm. Res. 2005, 22 (6), 999-1006.
http://biosurface.memphis.edu/images/ConfigCoordDiag2.png, “Luminescence.”
Hilfiker, R.; Berghausen, J.; Blatter, F.; Burkhard, A.; Paul, S. M. D.; Freiermuth, B.; Geoffory, A.; Hofmeier, U.; Marcolli, C.; Siebenhaar, B.; Szelagiewicz, M.; Vit, A.; Raumer, M. V. Polymorphism-Integrated Approach from High-throughput Screening to Crystallization Optimization. J. Therm. Anal. Calorim. 2003, 73 (2), 429-440.
Giron, D. Thermal Analysis, and Calorimetric Methods in the Characterisation of Polymorphs and Solvates. Thermochim. Acta 1995, 245 (2), 1-59.
Clas, S. D.; Dalton, C. R.; Hancock, B. C. Differential Scanning Calorimetry: Applications in Drug Development. Pharm. Sci. Technol. Today 1999, 2 (8), 311-320.
Lu, E.; Rodríguez-Hornedo, N.; Suryanarayanan R. A Rapid Thermal Method for Cocrystal Screening. CrystEngComm 2008, 10 (6), 665 – 668.
Skoog, D. A.; Holler, F. J.; Nieman, T. A. Thermal Methods. InPrinciples of Instrumental Analysis, 5th ed.; Thomson Learning: Mississippi, 2001; pp. 798-801.
Kriss, T. C.; Kriss, V. M.; Vensa, M. History of the Operating Microscope: From Magnifying Glass to Microneurosurgery. Neurosurgery 1998, 42 (4), 899-907.
http://www.cella.cn/jxck/02.ppt, “Methods and Techniques for Cell Biology.”
Pan, A.; Lin, X.; Liu, R.; Li, C.; He, X.; Gao, H.; Zou, B. Surface Crystallization Effects on The Optical and Electric Properties of CdS Nanorods. Nanotechnology 2005, 16 (10), 2402-2406.
Akpalu, Y.; Kielhorn, L.; Hsiao, B. S.; Stein, R. S.; Russell, T. P.; Egmond, J. V.; Muthukumar, M. Structure Development during Crystallization of Homogeneous Copolymers of Ethene and 1-Octene: Time-Resolved Synchrotron X-ray and SALS Measurements. Macromol. 1999, 32 (3), 765-770.
Li, C.; Kirkwood, K. L.; Brayer, G. D. The Biological Crystallization Resource: Facilitaing Knowledge-Based Protein Crystallization. Cryst. Growth Des. 2007, 7 (11), 2147-2152.
Wright, A. J.; McGauley, S. E.; Narine, S. S.; Willis, W. M.; Lencki, R. W. Marangoni, A. G. Solvent Effects on the Crystallization Behavior of Milk Fat Fractions. J. Agric. Food Chem. 2000, 48 (4), 1003-1040.
Ahari, H.; Bedard, R. L.; Bowes, C. L.; Coombs, N.; Dag, O. M.; Jiang, T.; Ozin, G. A.; Petroy, S.; Sokolov, I.; Verma, A.; Vovk, G.; Young, D. Effect of Microgravity on The Crystallization of a Self-assembling Layered Material. Nature 1997, 388 (6645), 857-860.
Morissette, S. L.; Almarsson, O.; Peterson, M. L.; Remenar, J. F.; Read, M. J.; Lemmo, A. V.; Ellis, S.; Cima, M. J.; Gardner, C. R. High-Throughput Crystallization: Polymorphs, Salts Co-crystals and Solvates of Pharmaceutical Solids. Adv. Drug Del. Rev. 2004, 56 (3), 275-300 (2004).
Basavoju, S.; Bostrom, D.; Velaga, S. P.; Pharmaceutical Cocrystal and Salts of Norfloxacin. Cryst. Growth Des. 2006, 6 (12), 2699-2708.
Braga, D.; Grepioni, F.; Making Crystals from Crystals: A Green Route to Crystal Engineering and Polymorphism. Chem. Commun. 2005, 7 (29), 3635-3645.
Hilfiker, R.; Berghausen, J.; Blatter, F.; Burkhard, A.; Paul, S. M. D.; Freiermuth, B.; Geoffroy, A.; Hofmeier, U.; Marcolli, C.; Siebenhaar, B.; Szeiagiewicz, M.; Vit, A.; Raumer, M. V. Polymorphism-Integrated Approach, from High-Throughput Screening to Crystallization Optimization. J. Therm. Anal. Calorim. 2003, 73 (2), 429-440.
Grant, D. J. W.; Theory and Origin of Polymorphism. In Polymorphism in Pharmaceutical Solids; Marcel Dekker: New York, 1999, pp 1-21.
Yurteri, C. U.; Mazumder, M. K.; Grable, N.; Ahuja, G.; Trigwell, S.; Biris, A. S.; Sharma, R.; Sims, R. A. Electrostatic Effects on Dispersion, Transport, and Deposition of Fine Pharmaceutical Powders: Development of an Experiment Method for Quantitative Analysis. Pharticulate Sci. Tech. 2002, 20 (1), 59-79.
York, P. Solid-State Properties of Powders in the Formulation and Processing of Solid Dosage Forms. Int. J. Pharm. 1983, 14 (1), 1-28.
Portalone, G.; Colapietro, M. Solid-Phase Molecular Recognition of Cytosine Based on Proton-Transfer Reaction. J. Chem. Crystallogr. 2009, 39 (3), 193-200.
Balasubramanian, T.; Muthiah, P. T.; Robinson, W. T. Cytosine-Carboxylate Interactions: Crystal Structure of Cytosineium Hydrogen Maleate. Bull. Chem. Soc. Jpn. 1996, 69 (10), 2919-2922.
Perumalla, S. R.; Suresh, E.; Pedireddi, V. R.; Nucleobases in Molecular Recognition: Molecular Adducts of adenine and Cytosine with COOH Functional Groups. Angew. Chem. Int. Ed. 2005, 44 (47), 7752-7757.
Yu, Z.; Li, W.; Hagen, J. A.; Zhou, Y.; Klotzkin, D.; Grote, J. G.; Steckl, A. J. Photoluminescence and Lasing Form Deoxyribonucleic Acid (DNA) Thin Doped with Sulforhodamine. Applied Optics 2007, 46 (9), 1507-1513.
Hagen, J. A.; Li, W.; Steckl, A. J.; Enhanced Emission Efficiency in Organic Light-Emitting Diodes Using Deoxyribonucleic Acid Complex As an Electron Blocking Layer. Appl. Phys. Lett. 2006, 88 (17), 1-3.
Brittain, H. G.; Grant, D. J. W.; Effect of Polymorphism and Solid-State Solvation on Solubility and Dissolution Rate. InPolymorphism in Pharmaceutical Solids; Marcel Dekker: New York, 1999; pp 279-330.
Bhattachar, S. N.; Deschenesa, L. A.; Wesleya, J. A. Solubility: It Is Not Just for Physical Chemists. Drug Discov. Today 2006, 11 (21-22), 1012-1018.
Price, C. J. Take Some Solid Steps to Improve Crystallization. Chem. Eng. Prog. 1997, 93 (9), 34-43.
Winn, D.; Doherty, M. F.; A New Technique for Predicting the Shape of Solution-Grown Organic Crystals. AlChE J. 1998, 44 (11), 2501-2514.
Mullin, J. W. Crystal Habit Modification. In Crystallization, 3rd ed.; Butterworth-Heinemann: London, 1997; pp 248-250.
Tiwary, A. K. Modification of Crystal habit and Its Role in Dosage from Performance. Drug Dev. Ind. Pharm. 2001, 27 (7), 699-709.
Rasenack, N.; Müller, B. W. Crystal Habit and Tabletting Behavior. Int. J. Pharm. 2002, 244 (1-2), 45-47.
Lahav, M.; Leiserowitz, L. The Effect of Solvent on Crystal Growth and Crystal Habit. Chem. Eng. Sci. 2001, 56 (7), 2245-2253.
Bernstein, J.; Davey, R. J.; Henck, J. Concomitant Polymorphs. Angew. Chem. Int. Ed. 1999, 38 (23), 3440-3461.
Cardew, P. T.; Davey, R. J.; The Kinetics of Solvent-Mediated Phase Transformation. Math. Phys. Sci. 1985, 398 (1815), 415-428.
Pack, K; Evans, J. M. B.; Myerson, A. S.; Determination of Solubility of Polymorphs Using Differential Scanning Calorimetry. Cryst. Growth. Des. 2003, 3 (6), 991-995.
Threfall, T.; Crystallization of Polymorphs: Thermodynamic Insight into the Role of Solvent. Org. Process Res. Dev. 2000, 4 (5), 384-390.
Yu, L. X.; Furness, M. S.; Raw, A.; Woodland Outlaw, K. P.; Nashed, N. E.; Ramos, E.; Miller, S. P. F.; Adams, R. C.; Fang, F.; Patel, R. M.; Holcombe Jr., F. O.; Chiu, Y.; Hussain, A. S. Scientific Considerations of Pharmaceutical Solid Polymorphism in Abbreviated New Drug Applications. Pharm. Res. 2004, 20 (4), 531-536.
Lee, T.; Kuo, C. S.; Chen, Y. H. Solubility, Polymorphism, Crystallinity, and Crystal Habit of Acetaminophen and Ibuprofen by Initial Solvent Scrrening. Pharm. Tech. 2006, 30 (10), 72-92.
Gao, D.; Raytting, J. H. Use of Solution Calorimetry to Determine the Extent of Crystallization of Drugs and Excipients. Int. J. Pharm. 1997, 151 (2), 183-192.
Schiedt, J.; Weinkauf, R.; Neumark, D. M.; Schlag, E. W. Anion Spectroscopy of Uracil, Thymine and the Amino-Oxo and Amino-Hydroxy Tautomers of Cytosine and Their Water Clusters. Chem. Phys. 1998, 239 (1-3), 511-514.
Barker, D. L.; Marsh, R. E. The Crystal Structure of Cytosine. Acta. Crytst. 1964, 17 (12), 1581-1587.
Jeffrey, G. A.; Kinoshita, Y. The Crystal Structure of Cytosine Monohydrate. Acta. Cryst. 1963, 16 (1), 20-28.
Ibahim, H. G.; Pisano, F.; Bruno, A. Polymorphism of Phenylbutazone: Properties and Compressional Behavior of Crystals. J. Pharm. Sci. 1977, 66 (5), 669-673.
Colthup, N. B.; Daly, L. H.; Wiberley, S. E. Major Spectra-Structure Correlations by Spectral Regions. InIntroduction to Infrared and Raman Spectroscopy, 3rd ed.; Academic Press Inc: New York, 1991; 394.
Cheney, M. L.; Weyna, D. R.; Shan, N.; Hanna, M.; Wojtas, L.; Zaworotko, M. J. Supramolecular Architectures of Meloxicam Carboxylic Acid Cocrystals, a Crystal Engineering Case Study. Cryst. Growth Des. 2010, 10 (10), 4401-4413.
Lee, T.; Wang, P. Y. Screening, Manufacturing, Photoluminescence, and Molecular Recognition of Co-crystals: Cytosine with Dicarboxylic Acids. Cryts. Growth Des. 2010, 10 (3), 1419-1434.
Shan, N.; Zaworotko, M. J. The Role of Cocrystals in Pharmaceutical Science. Drug Discovery Today 2008, 13 (9-10), 440–446.
Callear, S. K.; Hursthouse, M. B.; Threlfall, T. L. Co-crystallisation of organic α,ω-dicarboxylic acids with the cyclic amides 2-pyrrolidinone and 2-imidazolidinone. CrystEngComm 2009, 11 (8), 1609-1614.
Kastelic, J.; Hodnik, Ž.; Šket, P.; Plavec, J.; Lah, N.; Leban, I.; Pajk, M.; Planinšek, O.; Kikelj, D. Fluconazole Cocrystals with Dicarboxylic Acids. Cryst. Growth Des. 2010, 10 (11), 4943-4953.
Braga, D.; Grepioni, F.; Lampronti, G. I. Supramolecular Metathesis: co-former exchange in co-crystals of pyrazine with (R,R)-, (S,S)-, (R,S)- and (S,S/R,R)-tartaric acid. CrystEngComm 2011, 13 (9), 3122-3124.
Steiner, T. The Whole Palette of Hydrogen Bonds: The Hydrogen Bond in the Solid State. Angew. Chem. Int. Ed. 2002, 41 (1), 48-76.
Fayasankar, A.; Somwangthanaroj, A.; Shao, Z. J.; Rodríguez-Hornedo, N. Cocrystal Formation during Cogrinding and Storage is Mediated by Amorphous Phase. Pharm. Res.2006, 23(10), 2381-2392.
Olenik, B.; Smolka T.; Boese, R.; Sustmann, R. Supramolecular Synthesis by Cocrystallization of Oxalic and Fumaric Acid with Diazanaphthalenes. Cryst. Growth Des. 2003, 3 (2), 183-188.
Taylor, R.; Kennard, O. Crystallographic Evidence for the Existence of CH.cntdot.. cntdot..cntdot.O, CH.cntdot..cntdot..cntdot.N and CH.cntdot..cntdot..cntdot.CL hydrogen bonds. J. Am. Chem. Soc. 1982, 104 (19), 5063-5070.
Basavoju, S.; Bostrom, D.; Velaga, S. P. Indomethacin-Saccharin Cocrystal: Design, Synthesis and Preliminary Pharmaceutical Characterization. Pharm. Res. 2008, 25(3), 530-541.
McNamara, D. P.; Childs, S. L.; Giordano, J.; Iarriccio, A.; Cassidy, J.; Shet, M. S.; Mannion, R.; O’Donnell, E.; Park, A. Use of A Glutaric Acid Cocrystal to Improve Oral Bioavailability of A Low Solubility API. Pharm. Res. 2006, 23 (8), 1888-1897.
Ter Horst, J. H.; Deij, M. A. Cains, P. W. Discovering New Co-Crystals. Cryst. Growth Des. 2009, 9 (3), 1531–1537.
Zhang, G. G. Z.; Henry, R. F.; Borchardt, T. B.; Lou, X. Efficient Co-crystal Screening Using Solution-Mediated Phase Transformation. J. Pharm. Sci. 2007, 96 (5), 990–995.
Trask, A. V.; Samuel Motherwell, W. D.; Jones, W. Solvent-Drop Grinding: Green Polymorph Control of Co-crystallization. Chem. Commun. 2004, (7), 890–891.
Weyna, D. R.; Shattock, T.; Vishweshwar, P.; Zaworotko, M. J. Synthesis and Structural Characterization of Cocrystals and Pharmaceutical Cocrystals: Mechanochemistry vs. Slow Evaporation. Crys. Growth Des. 2009, 9 (2), 1106–1123.
Gagniere, E.; Mangin, D.; Puel, F.; Bebon, C.; Klein, J. P.; Monnier, O.; Garcia, E. Cocrystal Formation in Solution: In Situ Solute Concentration Monitoring of the Two Components and Kinetic Pathways. Cryst. Growth Des. 2009, 9 (8), 3376–3383.
Fris ̌c ̌ic ́, T.; Childs, S. L.; Rizvi, S. A. A.; Jones, W. The Role of Solvent in Mechanochemical and Sonochemical Cocrystal Formation: A Solubility-Based Approach for Predicting Cocrystallization Outcome. CrystEngComm 2009, 11 (3), 418–426.
Lu, E.; Rodríguez-Hornedo, N.; Suryanarayanan, R. A Rapid Thermal Method for Cocrystal Screening. CrystEngComm 2008, 10 (6), 665–668.
Ling, A. R.; Baker, J. L. Halogen derivatives of quinine. Part III. Derivatives of quinhydrone. J. Chem. Soc. 1893, 63, 1314-1327.
Trask, A. V.; Shan, N.; Motherwell, W. D. S.; Jones, W.; Feng, S.; Tan, R. B. H.; Carpenter, K. J. Selective Polymorph Transformation via Solvent-drop Grinding. Chem. Commun. 2005, (7), 880-882.
Trask, A. V.; Van de Streek, J.; Samuel Motherwell, W. D.; Jones, W. Achieving Polymorphic and Stoichiometric Diversity in Co-crystal Formation: Importance of Solid-State Grinding, Powder X-ray Structure Determination, and Seeding. Crys. Growth Des. 2005, 5(6), 2233-2241.
Blagden, N.; Berry, D. J.; Parkin, A.; Javed, H.; Ibrahim, A.; Gavan, P. T.; De Matos, L. L.; Seaton, C. C. Current Directions in Co-crystal Growth. New J. Chem. 2008, 32 (10), 1659-1672.
Shan, N.; Toda, F.; Jones, W. Mechanochemistry and Co-crystal Formation: Effect of Solvents on Reaction Kinetics. Chem. Commun. 2002, (20), 2372-2373.
Fris ̌c ̌ic ́, T.; Jones, W. Recent Advances in Understanding the Mechanism of Cocrystal Formation via Grinding. Crys. Growth Des. 2009, 9 (3), 1621-1637.
Trask, A. V.; Samuel Motherwell, W. D.; Jones, W. Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration. Crys. Growth Des. 2005, 5(3), 1013-1021.
Trask, A. V.; Jones, W. Crystal Engineering of Organic Cocrystals by the Solid-State Grinding Approach. Top Curr. Chem. 2005, 254, 41-70.
Perakyla, M. A Model Study of the Enzyme-Catalyzed Cytosine Methylation Using ab Initio Quantum Mechanical and Density Functional Theory Calculations: pKa of the Cytosine N3 in the Intermediates and Transition States of the Reaction. J. Am. Chem. Soc. 1998, 120 (49), 12895-12902.
Cheney, M. L.; Weyna, D. R.; Shan, N.; Hanna, M.; Wojtas, L.; Zaworotko, J. Supramolecular Architectures of Meloxicam Carboxylic Acid Cocrystals, a Crystal Engineering Case Study. Cryst. Growth Des. 2010, 10 (10), 4401-4413.
Strathmann, T. J.; Mayneni, S. C. B. Speciation of Aqueous Ni(II)-Carboxylate and Ni(II)-Fulvic Acid Solutions: Combined ATR-FTIR and XAFS analysis. Geochim. Cosmochim. Acta 2004, 68 (17), 3441-3458.
Wu, D. H.; Ge, J. Z.; Cai, H. L.; Zhang, W.; Xiong, R. G. Organic Salt of Hydrogen L-tartaric Acis: A Novel Wide-temperature-range Ferroelectrics with a Reversible Phase Transition. 2011, 13 (1), 319-324.
Child, S. L.; Patrick Stahly, G.; Park, A. The Salt-Cocrystal Continuum: The Influence of Crystal Structure on Ionization State. Mol. Pharmaceutics 2007, 4 (3), 323-338.
Johnson, S. L.; Rumon, K. A. Infrared Spectra of Solid 1:1 Pyridine-Benzoic Acid Complexes; the Nature of the Hydrogen Bond as a Function of the Acid-Base Levels in the Complex. J. Phys. Chem. 1965, 69 (1), 74-86.
Aakeroy, C. B.; Desper, J.; Fasulo, M. E. Improving Success Rate of Hydrogen-Bond Driven Synthesis of Co-crystals. CystEngComm 2006, 8 (8), 586-588.
Colthup, N. B.; Daly, L. H.; Wiberley, S. E.; Carbonyl Compounds In Introduction to infrared and Raman spectroscopy; Axademic Press Inc.: New York, USA, 1990, pp. 315,318.
Colthup, N. B.; Daly, L. H.; Wiberley, S. E.; Amines, C=N, and N=O Compounds In Introduction to Infrared and Raman Spectroscopy; Axademic Press Inc.: New York, USA, 1990, pp, 340,388.
Ataka, K.; Osawa, M. In Situ Infrared Study of Cytosine Adsorption on Gold Electrodes J. Electroanal. Chem. 1999, 460 (1), 188-196.
Smith, G.; Lynch, D. E.; Byriel, K. A.; Kennard, C. H. L. The Utility of 4-Aminobenzoic Acid in Promotion of Hydrogen Bonding in Crystallization Process: the Structures of the Cocrystals with Halo and Nitro Substituted Aromatic Compounds, and the Crystal Structures of the Adducts with 4-Nitroniline (1:1), 4-(4-Nitrobenzyl)pyridine (1:2), and (4-Nitrophenyl)acetic acid (1:1). J. Chem. Crystallogr. 1997, 27 (5), 307-317.
Florian, J.; Baumruk, V.; Leszczynski, J. IR and Raman Spectra, Tautomeric Stabilities, and Scaled Quantum Mechanical Force Fields of Protonated Cytosine. J. Phys. Chem. 1996, 100 (13), 5578-5589.
Saenger, W. Forces Stabilizing Associations Between Bases: Hydrogen Bonding and Base Stacking InPrinciples of Nucleic Acid Structure; Springer-Verlag: New York, USA, 1984, pp. 118-124.
Good, D. J.; Rodríguez-Hornedo, N. Solubility Advantage of Pharmaceutical Cocrystals. Cryst. Growth Des. 2009, 9 (5), 2252-2264.
Alhalaweh, A.; George, S.; Bostr m , D.; Velaga, S. P. 1:1 and 2:1 Urea−Succinic Acid Cocrystals: Structural Diversity, Solution Chemistry, and Thermodynamic Stability. Cryst. Growth Des. 2010, 10 (11), 4847-4855.
Jayasankar, A.; Sreenivas Reddy, L.; Bethune, S. J.; Rodríguez-Hornedo, N. Role of Cocrystal and Solution Chemistry on the Formation and Stability of Cocrystals with Different Stoichiometry. Cryst. Growth Des. 2009, 9 (2), 889-897.
Nehm, S. J.; Rodríguez-Spong, B.; Rodríguez-Hornedo, N. Phase Solubility Diagrams of Cocrystals Are Explained by Solubility Product and Solution Complexation. Cryst. Growth Des. 2006, 6 (2), 592-600.
|